PERK activation mitigates tau pathology in vitro and in vivo

Julius Bruch(German Center for Neurodegenerative Diseases), Günter U. Höglinger(German Center for Neurodegenerative Diseases)
EMBO Molecular Medicine
February 1, 2017
Cited by 124


Related Papers